Pancreatic acinar cell

Pancreatic acinar cells are specialized exocrine cells of the pancreas responsible for the synthesis, storage, and secretion of digestive enzymes (such as proteases, lipases, and amylases) that are released into the pancreatic duct and activated in the duodenum for nutrient digestion[1][2][6][7]. These cells comprise the majority of the pancreatic mass and display high rates of protein synthesis and export, involving intricate intracellular trafficking and signaling mechanisms, primarily regulated by calcium and neurohormonal inputs[2][3][6]. The premature activation of digestive enzymes within acinar cells contributes to the pathogenesis of acute pancreatitis, a major clinical disorder linked to these cells[4][7]. Pancreatic acinar cells also possess limited plasticity and can contribute to pancreatic cancer development[5]. Despite their importance in pathology (e.g., pancreatitis, cancer), pancreatic acinar cells are a cell type and not considered a direct therapeutic molecular target such as a receptor, enzyme, or transporter. Therapies often target their functions or consequences of their dysfunction (e.g., enzyme inhibition, modulation of signaling), but the cell itself is not itself a "target" in the canonical drug discovery sense[4][5][6]. This entry is "incorrect" as a molecular target, as it refers to a cell type rather than a specific molecule. No standardized abbreviation or biomarkers specific for patient selection are associated with pancreatic acinar cell as a therapeutic target. Relevant mechanisms and drugs act indirectly by affecting the cell's function or disease sequelae[4].

Other names

Acinar cellExocrine acinar cell

Enzyme inhibition, Antioxidant activity, Cytokine antagonism